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Correlation Between Myostatin and Lean Muscle Mass in Older Adults.
Abstract
Background: Our older adult population is growing exponentially and with it, the number of falls
and debilitating injuries that afflict their population grows as well. A fall brings with it many
possible injuries, healthcare costs, fear, and increased mortality. There seems to be a lack of
preventative measures in our healthcare system to help protect our elders. One possible measure
is a simple blood test that looks at the level of myostatin in a patient’s blood. Myostatin is a
negative regulator of muscle mass and therefore when myostatin is high muscle mass is low.
Low muscle mass places older adults at an increased risk for falls, an inability to complete
activities of daily living, and threatens their independence. Purpose: The purpose of this study
was to determine the correlation between the amount of myostatin a person has and their lean
muscle mass. We hypothesized that if a participant has a high level of myostatin in their blood a
healthcare provider could utilize that information to educate and implement preventative
measures that protect existing muscle and decrease fall risk. Methodology: Subjects consisted of
16 males and 24 females between the ages 60-90 years. All procedures took place in the Exercise
Science Research Center at the University of Arkansas. Each participant underwent a venous
blood draw and a full body scan utilizing the dual energy x-ray absorptiometry (DEXA). Blood
samples were analyzed using a myostatin ELISA test kit. Results: There was a positive
correlation between the levels of myostatin in the blood and the amount of lean muscle mass (r =
0.381). Therefore, as the myostatin increased in the blood the amount of lean muscle mass was
increased as well. Discussion: The results of this study are contradictory to the hypothesis and
other research in which muscle mass increased with a decrease in myostatin. The results suggest
the need for a larger sample size that closely resembles the general population in age and
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sarcopenic status. Future studies might also separate males and females to identify a difference in
myostatin levels between the genders as we age.

Introduction
By 2060 the population of adults 65 years or older in the United States is expected to
more than double (CDC, 2015) leading to a strain on the healthcare system. It is accepted
knowledge that as the body ages muscle mass is lost. The majority of older adults who do not
take part in physically active lifestyles risk losing up to 40% of their muscle mass after age 60
(Milanovic, Pantelic, Trajkovic, Sporis, Kostic & James, 2013). This loss of muscle mass can
cause difficulties in activities of daily living, as well as decreased functional fitness (Tuna,
Edeer, Malkoc & Aksakoglu, 2009). Functional fitness is defined as a sufficient physical fitness
level to manage activities of daily living safely and without fatigue (Tuna, Edeer, Malkoc &
Aksakoglu, 2009). It encompasses strength, speed, endurance, and the ability to perform
functional activities, such as, standing from a seated position, placing things overhead, pulling
oneself up, and tossing and picking up things. Without being able to accomplish these tasks older
adults have a decreased ability to do things they might have been able to in the past therefore
leading to increased dependency (Rikli & Jones, 1999) which leads to a low quality of life.
With lowered muscle mass comes an increase in fall risk (Guralnik, Fried & Salive,
1996). The number of falls increases by 35%-40% after 60 years of age, compared to other adults
under 60 years (Milanovic, Pantelic, Trajkovic, Sporis, Kostic & James, 2013). In the United
States, an older adult is being treated every 11 seconds for a fall and one dies every 19 minutes
from complications due to a fall (National Council On Aging, 2017). Falls contribute to an
estimated $31 billion annually in the US alone (National Council On Aging, 2017) and is
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expected to reach $67.7 billion by 2020 (National Council On Aging, 2017). While the cause of
falls is multifactorial (The Joint Commission, 2015), loss of muscle mass is a significant
contributor to a high risk of falls among older adults (Guralink, Fried, & Salive, 1996). Low
muscle mass has contributed approximately $19 billion to the cost of falls in the US healthcare
system (Janssen, Shepard, Katzmarzyk & Roubenoff, 2004). The Foundation for the National
Institute of Health (FNIH) defines sarcopenia as loss of muscle mass with age (Studenski, Peters
& Alley, 2014). Sarcopenia places older adults at a risk for a combination of decreased activities
of daily living, decreased functional fitness and increased falls.
As we age, it is essential to more fully understand the correlation between muscle mass
and its affects on our functional fitness. Usually, sarcopenia status is measured based on the
amount of lean muscle mass present plus the results of different exercises including the hand grip
strength and gait speed according to the Foundation for the National Institute of Health (FNIH)
Sarcopenia Project (Studenski, et al., 2014). Hand grip strength can be measured using a digital
Takei grip-strength dynamometer (Takei Scientific Instruments, Niigata City, Japan) which
could not be in the budget for some healthcare providers. In order to measure gait speed, time
needs to be set aside to watch each participant walk a total of 10 meters at their habitual walking
speed. These stipulations make these tests costly and time consuming in the clinical setting.
However, routine blood draws in the hospital or clinic are already established making them a
quicker alternative for testing. The blood biomarker myostatin has an inverse relationship with
the level of muscle mass in the body (Scimeca, Piccirilli & Mastrangeli, 2017), making it an
adequate predictor of muscle mass. Myostatin is found in individuals who have low muscle mass
(Scimeca, Piccirilli & Mastrangeli, 2017). If myostatin can be directly linked to the level of a
patient’s muscle mass, then clinicians can begin adding it to the blood draws that are already
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being performed in order to get more information on their patient’s muscle status. Testing for
myostatin has the potential to give healthcare providers an accurate idea of how much muscle
mass their patient has without expensive and time consuming procedures like a DXA scan or
sarcopenia evaluation test. A DXA scan is a non-invasive test that measures a patients bone
density to allow the clinician to assess for risk of osteoporosis or fracture. These scans can cost
between $134- $162 in Arkansas with the estimated national average being $365 (MDSave,
2019). Instead of using a DXA scan, simple blood tests meet the clinical need for a fast and
inexpensive maneuver to assess clients at risk for low muscle mass that could later lead to
expensive or fatal falls. If this project can support that low myostatin levels correlate with high
muscle mass, and visa versa, then there is a reason to clinically test for myostatin levels in older
adults to get a picture of their overall muscle mass. This would allow a blood test to be the first
screening tool for older adults as a preventative measure that allows doctors to make the
necessary judgments about education, interventions or further screening needed for their patient.
For example, if the patient has very high myostatin level the provider could then order a
diagnostic DXA scan to further understand the muscle mass loss. If the muscle mass loss is
indicated as mild, the provider can start lifestyle education with the patient about diet and
exercise changes that would help increase or maintain the patients current muscle status. With
these possible interventions in place we can begin to decrease the amount of falls older adults
suffer and increase their independence and quality of life.
Literature Review
Myostatin
The blood biomarker myostatin is not fully understood by researchers. Currently,
myostatin is thought to have an inverse relationship with muscle mass (Scimeca, Piccirilli &
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Mastrangeli, 2017); therefore, when one is low the other is high. It acts as a negative regulator of
muscle mass. Myostatin is a member of the transforming growth factor-beta superfamily and acts
on myoblasts to decrease myogenesis, or the creation of muscle tissue (Thomas et al., 2000).
Myostatin accomplishes this by preventing the myoblasts from completing the G1 to S-phase of
the cell cycle therefore inhibiting cell growth and reproduction (Thomas et al., 2000). The first
researchers to identify the myostatin gene in mice were McPherron and colleagues (1997). They
inhibited the myostatin gene, which resulted in mice with 2-3 times more muscle mass when
compared to their wild type counterparts (McPherron et al., 1997). This trend has continued to
hold true today. In the article ‘Myostatin and activin blockade by engineered follistatin results in
hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade
alone,’ researchers inactivated myostatin in mice and measured their resulting muscle mass
(Iskenderian et al., 2018). The researchers blocked the action of myostatin by administering
follistatin which acts as an antagonist against myostatin rendering it inactivated. It was shown
that the mice who were injected with follistatin had an increase in muscle size due to
hypertrophic enlargement of existing muscle fibers, and there was no generation of new muscle
fibers (Iskenderian et al., 2018). This muscle mass increase is not only limited to mice. There
have been other reports of naturally occurring myostatin mutations that result in excessive
muscle fiber hypertrophy in cattle, sheep, and dogs (Grobet et al, 1997; Clop et al, 2006; Mosher
et al, 2007). One human example is when a newborn was identified to have a myostatin null
mutation which caused an unusual amount of muscle mass at birth (Schuelke et al, 2004). These
results support that myostatin is a negative regulator of skeletal muscle and when in low
concentrations, muscles grow larger than average; however, when myostatin is present in large
concentrations, muscle mass is low.
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Low Muscle Mass
This potential for nulling myostatin expression, and essentially low muscle mass, is very
important among older adults. Adults between the ages of 30-80 years tend to have a decrease of
30-50% of muscle mass and strength (Milanovic, Pantelic, Trajkovic, Sporis, Kostic & James,
2013). This significant decrease in mass places older adults at risk for decreased ability to
complete activities of daily living (ADLs) and increased fall risk (Milanovic, Pantelic, Trajkovic,
Sporis, Kostic & James, 2013). ADLs include eating, bathing, dressing, toileting, and
transferring. All of which are common every day activities we do normally do without a second
thought. Their decline in functional capacity includes strength, endurance, agility, and flexibility
(Tuna, Edeer, Malkoc & Aksakoglu, 2009) which directly affects their ADLs. Older adults
between the ages 70-80 years have been found to have a reduction in functional fitness when
compared to the 60-69 age group (Milanovic, Pantelic, Trajkovic, Sporis, Kostic & James,
2013). The differences between the age groups were due to reduction in muscle strength in both
upper and lower limbs, changes in body fat percentage, and a decrease in flexibility, agility, and
endurance. Functional fitness is the physical ability to complete normal everyday activities
independently and without the onset of fatigue (Milanovic, Pantelic, Trajkovic, Sporis, Kostic &
James, 2013). With the loss of their ability to complete simple personal care tasks for themselves
it makes sense that as muscle mass decreases, independence decreases as well. It has been found
that low muscle mass and low muscle function predispose older adults for being at risk for losing
physical independence later in life (Santos, Cyrino, Antunes, Santos, & Sardinha, 2016). This
loss of independence not only has a huge impact on the patient but also the whole family unit as
they try and care for their aging loved ones.
Sarcopenia
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Some older adults have lost a significant amount of muscle mass and are now labeled as
sarcopenic. Sarcopenia is the aging-induced generalized pathological condition characterized by
loss of muscle mass and physical function related to aging (Scimeca et al, 2017). It joins
osteoporosis and osteoarthritis as one of the most frequent musculoskeletal disorders to afflict
older people (Scimeca et al., 2017). Sarcopenia has been found to be a major predictor of frailty,
hip fracture, disability, and mortality in older adults (Yanai, 2015). Some of the contributing
factors to sarcopenia are the aging process, poor nutrition, bed rest, sedentary lifestyle, chronic
disease, and certain drug treatments (Cruz-Jentoft et al., 2010). Almost all of these can be found
in our older adult population placing most of them at high risk. Sadly, the common outcome of
sarcopenia is falls and fractures leading to bedridden patients with an increased risk of mortality
(Scimeca et al., 2017). Many studies have been conducted to find a potential treatment to reverse
sarcopenia and muscle loss in older adults and most have found resistance training conducted at
high intensity produces substantial improvements in strength. Some examples of resistance
training would be leg press, bicep curl, push press, leg extension, and leg curl. In order to do
these exercises one needs to know how to do them correctly and have access to gym machines.
This also requires the adults to have the transportation and financial means to do so. Both of
these may be challenging to fulfill for most of America’s elderly between the age of 60-90 as
40% of them are estimated to experience at least one year below the poverty line (Rank &
Hirshchl, 1999). With all these barriers stacked up against America’s older adults, a solution to
recognize low muscle mass before it leads to sarcopenia and debility needs to be found.
Falls
One major complication from low muscle mass, old age, and sarcopenia is falling. The
number of falls after 60 years of age increases by 35-40% (Milanovic, Pantelic, Trajkovic,
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Sporis, Kostic & James, 2013). Every 11 seconds an older adult is being treated for a fall and
every 19 seconds one person dies from complications secondary to a fall (National Council On
Aging, 2017). Even after hospitalization due to illness or injury it was found that disability
developed among 55.3% of the participants and 79.6% of them had at least one episode of
restricted activity (Gill, Allore, Holford, & Guo, 2004). These statistics seem very high
considering The United States’ advancement in healthcare. When it comes to the cost of falls,
$31 billion annually is the price Americans have to pay (National Council On Aging, 2017).
These costs are only expected to go up as our population of adults 65 years or older is expected
to double by 2060 (CDC, 2015). It was found that low muscle mass contributes $19 billion to the
cost of falls in the US healthcare system (Janssen, Shepard, Katzmarzyk, & Roubenoff, 2004).
And while the cause of falling is multifactorial, low muscle mass is a huge chunk of the cost that
could be preventable with the appropriate testing and interventions.
A Solution is Needed
When anyone is hospitalized it is a standard procedure to perform a venous blood draw
for various laboratory tests. Usually these help healthcare providers diagnose and treat the
patient’s current illness or problem. If my hypothesis is correct and high myostatin levels can
indicate low muscle mass, we can start preventative testing on older adults to preserve their
remaining muscle mass. This would be a very different view of healthcare where we move from
treating the patient and their current illness to anticipating the patients’ future complications and
educating against them. Testing myostatin levels with the resources most hospital labs have
should be no problem. Early detection of older adults at risk for losing physical independence
and a better understanding of the associated factors are key for healthy aging (Fried, Ferrucci,
Darer, Williamson, & Anderson, 2004). Some of these interventions are high intensity resistance
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training, nutritional support, and supplementation. It has been found that a couple of months of
strength training essentially reverses two decades of strength loss and muscle atrophy even in
advanced age (Hurley & Roth, 2000). Malnutrition is one of the factors contributing to
sarcopenia and in order to avoid loosing muscle mass older adults need to intake 25-30g of high
quality protein at each meal (Yanai, 2015). Supplementation of vitamin D and essential amino
acids are also significant protective interventions in preventing sarcopenia development in high
risk individuals (Yanai, 2015). So, with data from a simple blood draw, physicians can educate
and implement some of these interventions that will slow the progression of muscle loss, prevent
falls and extend the quality of life for our older adults.

Methodology
Forty individuals (n = 24 F, n = 16 M) participated in the study with the mean age of 67.7 years
(Table 1).

Before testing, each participant signed an informed consent and underwent a Dual Energy
X-ray Absorptiometry (DEXA) scan to determine total lean muscle mass. A venipuncture was
then performed to draw a blood sample from each participant. To test the blood samples of each
participant an enzyme-linked immunosorbent assay (ELISA) was performed in the University of
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Arkansas Exercise Science Research Laboratory. A correlation was than ran with the myostatin
levels and the total lean muscle mass of each participant. All measures and procedures were
approved by the University’s Institutional Review Board.
Results
At the end of the study a correlation was ran between the lean muscle mass of each
participant and their myostatin value. The muscle mass was obtained with a DEXA scan and the
myostatin levels were from the ELISA assay ran on each blood sample. The outcome was a weak
positive correlation (r = 0.38; Figure 1). So as myostatin levels increase in the blood, muscle
mass also increases.

Myostatin vs Total Lean
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80000
70000
60000
50000
40000
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10000
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Figure 1. Correlation of Myostatin levels and total lean muscle mass (r = 0.38).
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Discussion
The current study hypothesized that myostatin blood levels will have an inverse
relationship with muscle mass. Therefore, the higher the myostatin level, the lower the muscle
mass. The current study failed to produce any significant inverse relationships between
myostatin and muscle mass. The end result of a weak positive correlation between lean muscle
mass and myostatin levels revealed that as myostatin increases, muscle mass rises as well. This is
contradictory to similar research done on the myostatin and muscle mass relationship, where
there is usually a strong negative correlation.
The sample size of this participant population of 40 does not accurately reflect the real
world population in relation to sarcopenic average. The prevalence of sarcopenia in community
dwelling older adults can reach up to 29% (Delmonico and Beck, 2017). I only had four
participants that were labeled as sarcopenic in my project which is only 10% of my population. If
my population had the 29% sarcopenic average the myostatin level might be higher since
increased myostatin levels are found in people with sarcopenia (White and LeBrasseur, 2014).
Some limitations of this project are mechanical dysfunction while running the ELISA test
resulting in skewed data. If time had not been a constraint, we would have reanalyzed the
myostatin samples. It was also not in the budget to purchase another ELISA kit. I think this
project would have benefited from a higher population of participants. I don’t think 40 samples
was enough to accurately depict the average muscle mass or blood myostatin levels in older
adults in America. If I was to repeat the project, I would have at least 100 participants over 65
years of age with the majority being female since there are 126 females over the age of 65 for
every 100 males (2017 Profile of Older Americans, 2018).
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